about
Neurosurgical Techniques for Disruption of the Blood-Brain Barrier for Glioblastoma Treatment.Anaplastic ganglioglioma: a report of three cases and review of the literatureLocal control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: is there a volume threshold for toxicity?The Effects of smoking status and smoking history on patients with brain metastases from lung cancer.Use of 3.0-T MRI for stereotactic radiosurgery planning for treatment of brain metastases: a single-institution retrospective review.Predictive nomogram for the durability of pain relief from gamma knife radiation surgery in the treatment of trigeminal neuralgia.A new method for modulating traumatic brain injury with mechanical tissue resuscitation.Comparison of clinical outcomes and genomic characteristics of single focus and multifocal glioblastomaRecurrent malignant glioma in adults.Neurosurgical management of low- and intermediate-grade gliomas.Improved efficacy of temporally non-regular deep brain stimulation in Parkinson's diseaseSubsecond dopamine fluctuations in human striatum encode superposed error signals about actual and counterfactual rewardInfluenza vaccine immunogenicity in patients with primary central nervous system malignancy.Limited margins using modern radiotherapy techniques does not increase marginal failure rate of glioblastoma.Genomic predictors of patterns of progression in glioblastoma and possible influences on radiation field designRepeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.A phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme.Factors that determine local control with gamma knife radiosurgery: The role of primary histology.Laser Ablation of Recurrent Malignant Gliomas: Current Status and Future Perspective.Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases.Regulation of the acute phase and immune responses in viral disease. Enhanced expression of the beta 2-interferon/hepatocyte-stimulating factor/interleukin 6 gene in virus-infected human fibroblastsLeptomeningeal failure in patients with breast cancer receiving stereotactic radiosurgery for brain metastases.Short pauses in thalamic deep brain stimulation promote tremor and neuronal bursting.Neuroanatomical target theory as a predictive model for radiation-induced cognitive decline.Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trialCortisol infusion in late-gestation hypothalamo-pituitary disconnected sheep fetus restores pituitary cell responsiveness to arginine vasopressin.A phase II trial of thalidomide and procarbazine in adult patients with recurrent or progressive malignant gliomas.Gamma knife stereotactic radiosurgery as salvage therapy after failure of whole-brain radiotherapy in patients with small-cell lung cancerWeight change following deep brain stimulation for movement disorders.Radiation oncology in brain tumors: current approaches and clinical trials in progress.Convection-enhanced delivery to achieve widespread distribution of viral vectors: Predicting clinical implementation.Gamma knife radiosurgery in the treatment of tumor-related facial pain.Gamma knife stereotactic radiosurgery for radiation-induced meningiomas.Definitive treatment of vein of Galen aneurysmal malformation with stereotactic radiosurgery.Radiosurgical management of trigeminal neuralgia.Patterns of recurrence after stereotactic radiosurgery for treatment of meningiomas.Neuronal oscillations in Parkinson's disease.Is there a tumor volume threshold for postradiosurgical symptoms? A single-institution analysis.Repeat Radiosurgery for Trigeminal Neuralgia.Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogram.
P50
Q26801485-3CAB58A5-83CA-4FF5-BAF0-A47E0790A26EQ30929403-BFE1509B-5429-43C7-8902-2E1C9E35A638Q33603180-6A3E143E-D6A7-41C4-BB3C-77087D958610Q33679559-07E53725-59D8-46DB-8FEA-EB1251F5F2A1Q33690139-AE59ABB9-03FC-42E5-8418-4B95B96BAFA4Q34023524-535FA67E-6589-4E8F-81DD-3727D68AE2FEQ34096307-6A51B7E1-A3A7-4BF7-88EC-2B3532F4ABA6Q34098218-D36915E1-7D49-4C1D-89C2-DBAA065F683BQ34155598-EF2CA7D2-0C8F-4AF3-8528-E8C4360F7B4AQ34206537-3B380BFF-AFE6-4914-BFBB-5841759CD5DFQ34302698-B3A72AC9-1141-4843-99ED-C6F5672695E8Q34502734-C3EB99D0-834A-413C-A8C1-4856C964EBDCQ34511678-B20D2B12-B47F-4228-A5AD-6C9640C35371Q35797779-79F25575-4137-429B-8B6F-E6BCB7819F8CQ36096097-B2D81F67-C505-4423-9390-6F3BBB463E6CQ36096164-AF32C6FC-6FC6-43AB-8333-9D1E753B3990Q36100686-85493D9B-22C6-4A9E-B3E8-F09F1C4959D0Q36161425-57221548-88EB-4C09-8ECB-C9ADF3DD7DA8Q36196954-653B6F87-B03B-4100-AE06-8F74417B5CB1Q36326292-33C390DF-43C4-4CAA-9DF1-A256E4F9519BQ36357674-AD36DDC0-57E9-428A-9644-9532283E79FAQ36373586-6F3FBF39-E92F-4DF9-B98A-2860083EF754Q36563781-13480677-43B6-492D-AC6C-34A073A567E2Q36659730-28571F4C-18AF-47F2-AF26-7198F5BCEE37Q36915049-72589A93-14B1-4679-A6D3-8F448ED25334Q37102872-E34A51F3-FDFC-4AF1-960E-72233E0AFAABQ37192227-F75DF632-EF19-4C8C-9930-1B6912D73B77Q37217776-DAB4E6F9-C746-49F7-A2A5-E5B4FB1C36BEQ37707180-EA29AEA8-57D8-46AC-B050-450D6EC61E8FQ37779874-F72D6155-7C41-4233-A148-70178F46E561Q37820530-56D5917C-EE4D-4909-8ED6-7BE72B7A7CF5Q38003041-8BD673D1-D739-4E40-A903-D5B7A221B33AQ38038014-5A11DF74-3E5B-483B-B279-EFE7D0782AF1Q38122760-C95448BB-2DA5-42E7-984B-8716D1382726Q38149178-8A0E5ED1-9830-4EBB-8E53-C26AB0CD9F69Q38167334-C28EBE41-56A9-4101-B9D8-0AF8A04A0E57Q38217568-048A3627-C72F-438F-B739-9B06850E1BE0Q38244601-C12D2343-4AAD-4CD7-AA16-763DF11DA2F2Q38555056-E1FC191B-C658-4D2F-90B7-3D59E08D5901Q38614732-64468FF0-CB24-4C86-AFBF-37CCE2CAE6A7
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stephen B Tatter
@ast
Stephen B Tatter
@en
Stephen B Tatter
@es
Stephen B Tatter
@nl
type
label
Stephen B Tatter
@ast
Stephen B Tatter
@en
Stephen B Tatter
@es
Stephen B Tatter
@nl
prefLabel
Stephen B Tatter
@ast
Stephen B Tatter
@en
Stephen B Tatter
@es
Stephen B Tatter
@nl
P106
P31
P496
0000-0002-1063-0431